Zynex Return on Tangible Equity 2012-2025 | ZYXIQ
Current and historical return on tangible equity values for Zynex (ZYXIQ) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| Zynex Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-09-30 | $-0.07B | $-0.02B | 448.48% |
| 2025-06-30 | $-0.03B | $0.00B | 682.35% |
| 2025-03-31 | $-0.01B | $0.00B | -228.57% |
| 2024-12-31 | $0.00B | $0.01B | 30.77% |
| 2024-09-30 | $0.00B | $0.01B | 44.44% |
| 2024-06-30 | $0.01B | $0.02B | 41.38% |
| 2024-03-31 | $0.01B | $0.02B | 37.21% |
| 2023-12-31 | $0.01B | $0.03B | 34.48% |
| 2023-09-30 | $0.02B | $0.03B | 47.41% |
| 2023-06-30 | $0.02B | $0.04B | 48.57% |
| 2023-03-31 | $0.02B | $0.04B | 46.58% |
| 2022-12-31 | $0.02B | $0.04B | 40.76% |
| 2022-09-30 | $0.02B | $0.04B | 43.90% |
| 2022-06-30 | $0.02B | $0.05B | 39.58% |
| 2022-03-31 | $0.02B | $0.05B | 36.19% |
| 2021-12-31 | $0.02B | $0.06B | 30.91% |
| 2021-09-30 | $0.01B | $0.06B | 17.17% |
| 2021-06-30 | $0.01B | $0.06B | 8.93% |
| 2021-03-31 | $0.01B | $0.05B | 10.31% |
| 2020-12-31 | $0.01B | $0.04B | 22.36% |
| 2020-09-30 | $0.01B | $0.03B | 32.26% |
| 2020-06-30 | $0.01B | $0.02B | 51.16% |
| 2020-03-31 | $0.01B | $0.02B | 54.79% |
| 2019-12-31 | $0.01B | $0.02B | 58.06% |
| 2019-09-30 | $0.01B | $0.01B | 70.59% |
| 2019-06-30 | $0.01B | $0.01B | 90.91% |
| 2019-03-31 | $0.01B | $0.01B | 105.26% |
| 2018-12-31 | $0.01B | $0.01B | 129.03% |
| 2018-09-30 | $0.01B | $0.01B | 148.15% |
| 2018-06-30 | $0.01B | $0.01B | 180.00% |
| 2018-03-31 | $0.01B | $0.00B | 360.00% |
| 2017-12-31 | $0.01B | $0.00B | 1400.00% |
| 2017-09-30 | $0.00B | $0.00B | -228.57% |
| 2017-06-30 | $0.00B | $0.00B | -92.31% |
| 2017-03-31 | $0.00B | $0.00B | -25.00% |
| 2016-12-31 | $0.00B | $0.00B | -23.53% |
| 2016-09-30 | $0.00B | $0.00B | 0.00% |
| 2016-06-30 | $0.00B | $0.00B | 25.00% |
| 2016-03-31 | $0.00B | $0.00B | 28.57% |
| 2015-12-31 | $0.00B | $0.00B | 66.67% |
| 2015-09-30 | $0.00B | $0.00B | 0.00% |
| 2015-06-30 | $0.00B | $0.00B | 0.00% |
| 2015-03-31 | $-0.01B | $0.00B | 342.86% |
| 2014-12-31 | $-0.01B | $0.00B | 1200.00% |
| 2014-09-30 | $-0.01B | $0.00B | -1200.00% |
| 2014-06-30 | $-0.01B | $0.00B | -346.67% |
| 2014-03-31 | $-0.01B | $0.01B | -133.33% |
| 2013-12-31 | $-0.01B | $0.01B | -91.43% |
| 2013-09-30 | $0.00B | $0.01B | -29.27% |
| 2013-06-30 | $0.00B | $0.01B | -18.60% |
| 2013-03-31 | $0.00B | $0.01B | 0.00% |
| 2012-12-31 | $0.00B | $0.01B | 0.00% |
| 2012-09-30 | $0.00B | $0.01B | 9.52% |
| 2012-06-30 | $0.00B | $0.01B | 20.00% |
| 2012-03-31 | $0.00B | $0.01B | 21.05% |
| 2011-12-31 | $0.00B | $0.01B | 22.22% |
| 2011-09-30 | $0.00B | $0.01B | 11.76% |
| 2011-06-30 | $0.00B | $0.01B | 0.00% |
| 2011-03-31 | $0.00B | $0.01B | 0.00% |
| 2010-12-31 | $0.00B | $0.01B | 0.00% |
| 2010-09-30 | $0.00B | $0.01B | 0.00% |
| 2010-06-30 | $0.00B | $0.01B | 0.00% |
| 2010-03-31 | $0.00B | $0.01B | 14.81% |
| 2009-12-31 | $0.00B | $0.01B | 32.00% |
| 2009-09-30 | $0.00B | $0.01B | 34.78% |
| 2009-06-30 | $0.00B | $0.01B | 33.33% |
| 2009-03-31 | $0.00B | $0.01B | 16.00% |
| 2008-12-31 | $0.00B | $0.01B | 0.00% |
| 2008-09-30 | $0.00B | $0.01B | 16.67% |
| 2008-06-30 | $0.00B | $0.01B | 42.11% |
| 2008-03-31 | $0.00B | $0.00B | 57.14% |
| 2007-12-31 | $0.00B | $0.00B | 72.73% |
| 2007-09-30 | $0.00B | $0.00B | 50.00% |
| 2007-06-30 | $0.00B | $0.00B | 0.00% |
| 2007-03-31 | $0.00B | $0.00B | 0.00% |
| 2006-12-31 | $0.00B | $0.00B | 0.00% |
| 2006-09-30 | $0.00B | $0.00B | 0.00% |
| 2006-06-30 | $0.00B | 0 | 0.00% |
| 2006-03-31 | $0.00B | 0 | 0.00% |
| 2005-12-31 | $0.00B | 0 | 0.00% |
| 2005-09-30 | $0.00B | 0 | 0.00% |
| 2005-06-30 | $0.00B | 0 | 0.00% |
| 2005-03-31 | $0.00B | $0.00B | 0.00% |
| 2004-12-31 | $0.00B | $0.00B | 0.00% |
| 2004-09-30 | $0.00B | $0.00B | 0.00% |
| 2004-06-30 | $0.00B | 0 | 0.00% |
| 2004-03-31 | $0.00B | -0 | 0.00% |
| 2003-12-31 | $0.00B | $0.00B | 0.00% |
| 2003-09-30 | $0.00B | $0.00B | 0.00% |
| 2003-03-31 | $0.00B | $0.00B | 0.00% |
| 2002-12-31 | $0.00B | $0.00B | 0.00% |
| 2002-06-30 | $0.00B | $0.00B | 0.00% |
| 2002-03-31 | $0.00B | $0.00B | 0.00% |
| 2001-12-31 | $0.00B | $0.00B | 0.00% |
| 2001-09-30 | $0.00B | $0.00B | 0.00% |
| 2001-06-30 | $0.00B | $0.00B | 0.00% |
| 2001-03-31 | $0.00B | -0 | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.001B | $0.192B |
| Zynex, Inc. engineers, manufactures, markets, and sells medical devices for the electrotherapy, and stroke and spinal cord injury rehabilitation markets primarily in the United States. The company primarily offers electrotherapy products for pain relief and pain management; and NeuroMove for stroke and spinal cord injury rehabilitation. The company's product lines are fully developed, FDA-cleared, commercially sold, and have been developed to uphold the Company's mission of improving the quality of life for patients suffering from impaired mobility due to stroke, spinal cord injury, or debilitating and chronic pain. Zynex markets its products through commissioned and independent sales representatives, as well as directly to end users through advertisements and articles in relevant publications and on the Internet. The company is headquartered in Littleton, Colorado. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $174.688B | 19.48 |
| Stryker (SYK) | United States | $129.889B | 24.88 |
| Medtronic (MDT) | Ireland | $111.968B | 15.57 |
| EssilorLuxottica (ESLOY) | France | $107.724B | 0.00 |
| Boston Scientific (BSX) | United States | $91.831B | 20.26 |
| Medline (MDLN) | United States | $59.904B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $45.712B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $33.391B | 15.98 |
| ResMed (RMD) | United States | $33.341B | 22.26 |
| Agilent Technologies (A) | United States | $32.516B | 20.44 |
| Koninklijke Philips (PHG) | Netherlands | $27.260B | 16.18 |
| Terumo (TRUMY) | Japan | $19.854B | 23.21 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.025B | 11.36 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $14.227B | 0.00 |
| Insulet (PODD) | United States | $13.640B | 39.54 |
| Baxter (BAX) | United States | $8.854B | 7.56 |
| Sunny Optical Technology (SNPTF) | China | $8.381B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.537B | 28.15 |
| Demant (WILYY) | Denmark | $6.395B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $5.247B | 15.90 |
| Envista Holdings (NVST) | United States | $4.301B | 21.99 |
| BillionToOne (BLLN) | United States | $3.729B | 0.00 |
| DiaSorin S.p.A (DSRLF) | Italy | $3.666B | 0.00 |
| ICU Medical (ICUI) | United States | $3.141B | 20.47 |
| Prestige Consumer Healthcare (PBH) | United States | $2.676B | 12.62 |
| Haemonetics (HAE) | United States | $2.664B | 11.65 |
| LeMaitre Vascular (LMAT) | United States | $2.611B | 48.16 |
| Phibro Animal Health (PAHC) | United States | $2.347B | 20.67 |
| GN Store Nord (GNNDY) | Denmark | $2.270B | 21.90 |
| Neogen (NEOG) | United States | $2.050B | 44.86 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.028B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $1.794B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.654B | 32.89 |
| Curaleaf Holdings (CURLF) | Canada | $1.584B | 0.00 |
| Perrigo (PRGO) | Ireland | $1.495B | 3.96 |
| AtriCure (ATRC) | United States | $1.429B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.386B | 15.91 |
| Kestra Medical Technologies (KMTS) | United States | $1.043B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.953B | 164.50 |
| QuidelOrtho (QDEL) | United States | $0.943B | 6.53 |
| Lumexa Imaging Holdings (LMRI) | United States | $0.896B | 0.00 |
| InMode (INMD) | Israel | $0.857B | 9.40 |
| Omeros (OMER) | United States | $0.827B | 6.49 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.789B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.766B | 0.00 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Brainsway (BWAY) | Israel | $0.546B | 55.68 |
| Valneva SE (VALN) | France | $0.532B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.468B | 11.18 |
| Cresco Labs (CRLBF) | United States | $0.458B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.415B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.367B | 25.70 |
| SNDL (SNDL) | Canada | $0.366B | 0.00 |
| Cerus (CERS) | United States | $0.363B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.311B | 126.00 |
| Evolus (EOLS) | United States | $0.278B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.259B | 0.00 |
| MacroGenics (MGNX) | United States | $0.229B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Accendra Health (ACH) | United States | $0.215B | 2.96 |
| Utah Medical Products (UTMD) | United States | $0.210B | 18.94 |
| High Tide (HITI) | Canada | $0.205B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.205B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.194B | 57.17 |
| TerrAscend (TSNDF) | Canada | $0.193B | 0.00 |
| Organigram Global (OGI) | Canada | $0.191B | 0.00 |
| Apyx Medical (APYX) | United States | $0.166B | 0.00 |
| Quanterix (QTRX) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.157B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.152B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.145B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.143B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.133B | 0.00 |
| Fonar (FONR) | United States | $0.115B | 16.53 |
| Jushi Holdings (JUSHF) | United States | $0.101B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.090B | 11.73 |
| Exagen (XGN) | United States | $0.073B | 0.00 |
| Sharps Technology (STSS) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.064B | 0.00 |
| Biote (BTMD) | United States | $0.063B | 3.46 |
| INLIF (INLF) | China | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.038B | 0.00 |
| Veru (VERU) | United States | $0.038B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.036B | 0.00 |
| Nephros (NEPH) | United States | $0.032B | 26.91 |
| United-Guardian (UG) | United States | $0.030B | 14.23 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.018B | 0.00 |
| Modular Medical (MODD) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Flora Growth (FLGC) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Agape ATP (ATPC) | $0.003B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |